Try our mobile app

Switch to company model in classical logic    *

General information

Country: UNITED STATES

Sector: Scientific and Technical Instruments

Mesa Laboratories, Inc. acquires, develops, manufactures, and markets electronic measurement instruments used by industrial and hemodialysis customers. The Company"s products include pipeline flow meters and instruments used for calibrating hemodialysis and proportioning equipment, temperature sensors, and data recorders. Mesa is also exploring alternative uses of their technologies.
Website: mesalabs.com



Growth: Pretty weak revenue growth rate 3.2%, there is slowdown compared to average historical growth rates 6.0%. The revenue growth dynamics is unstable

Profitability: LTM EBITDA margin is positive, +12.5%. On average the margin is decreasing steadily. In the last quarter the company did not beat the estimated EPS, -70.3%. The company was ahead of estimated EPS in 20% of quarters (showing a gain of -$0.37 per share on average)

Cash Flow Generation: Dividend yield for the last twelve months 0.5%. Free cash flow yield 15.9% (LTM)

Undervaluation: Fundamental value created in LTM (estimate)


Entry Point: Share price is 110.4% higher than minimum and 20.4% lower than maximum for the last 3 years

AI Insight: the companies with similar growth trajectories, EBITDA margin, industries and geography on average are valued 2.4x by EV / Sales multiple , the company can be 33.0% overvalued

Insiders: For the last 3 months insiders sold company shares on $0.7 mln (-0.139% of cap.)

Key Financials (Download financials)

Ticker: MLAB
Share price, USD:  (-0.4%)120.87
year average price 88.04  


year start price 61.66 2025-09-14

min close price 61.66 2025-09-14

max close price 130.65 2026-09-02

current price 120.87 2026-09-13
Common stocks: 5 297 000

Dividend Yield:  0.5%
FCF Yield LTM: 15.9%
EV / LTM EBITDA: 28.2x
EV / EBITDA annualized: 24.3x
Last revenue growth (y/y):  +3.2%
Last growth of EBITDA (y/y):  0.0%
Historical revenue growth:  +6.0%
Historical growth of EBITDA:  +13.7%
EV / Sales: 3.5x
Margin (EBITDA LTM / Revenue): 12.5%
Fundamental value created in LTM:
Market Cap ($m): 640
Net Debt ($m): 234
EV (Enterprise Value): 874
Price to Book: 3.6x

Revenue and EBITDA

Quarterly values ($m)

Change (y/y)

Cash Flow

FCF ($m)

Net Debt / Cash and Equivalents ($m)

Share price and dividends (Download history)

Share price

Payment USD per share

Multiple and potential

EV / Sales

Potential dynamics

News


2026-01-15seekingalpha.com

Mesa Laboratories, Inc. (MLAB) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

2025-11-12globenewswire.com

Mesa Laboratories, Inc. to Participate in Upcoming Investor Conferences

2025-10-03globenewswire.com

Mesa Laboratories, Inc. to Announce Second Quarter Results on November 6, 2025

2025-08-18globenewswire.com

Mesa Laboratories Executes Previously-Announced Strategic Financing Plan

2025-08-05zacks.com

Mesa Labs (MLAB) Lags Q1 Earnings and Revenue Estimates

2025-07-02globenewswire.com

Mesa Laboratories, Inc. to Announce First Quarter Results on August 5, 2025

2025-05-28zacks.com

Mesa Labs (MLAB) Q4 Earnings and Revenues Lag Estimates

2025-03-26zacks.com

What Makes Mesa Labs (MLAB) a New Strong Buy Stock

2025-02-11zacks.com

Why Mesa Labs (MLAB) Might be Well Poised for a Surge

2025-02-04zacks.com

Mesa Labs (MLAB) Q3 Earnings and Revenues Beat Estimates
More information for subscribed users:
detailed calculation of
Fundamental value created in LTM

Financial reporting

Income Statement

Property 2025 q3 2025 q2 2025 q1 2024 q3 2024 q2 2024 q1 2023 q4 2023 q3 2023 q2 2023 q1 2022 q4 2022 q3 2022 q1 2021 q1
date 2025-09-30 2025-06-30 2025-03-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-03-31 2021-03-31
symbol MLAB MLAB MLAB MLAB MLAB MLAB MLAB MLAB MLAB MLAB MLAB MLAB MLAB MLAB
reportedCurrency USD USD USD USD USD USD USD USD USD USD USD USD USD USD
cik 724 004 724 004 724 004 724 004 724 004 724 004 724 004 724 004 724 004 724 004 724 004 724 004 724 004 724 004
fillingDate 2025-11-06 2025-08-05 2024-11-07 2024-08-05 2024-02-05 2023-11-06 2023-08-03 2023-02-06 2022-11-03
acceptedDate 2025-11-06 16:51:17 2025-08-05 08:01:12 2025-05-28 08:01:28 2024-11-07 08:05:59 2024-08-05 08:00:59 2024-06-28 17:02:32 2024-02-05 08:01:38 2023-11-06 08:00:52 2023-08-03 08:00:58 2023-05-30 08:01:03 2023-02-06 08:00:41 2022-11-03 08:01:16 2022-05-31 16:09:45 2021-06-01 11:04:21
calendarYear 2026 2026 2025 2025 2024 2024 2024 2023 2023
period Q2 Q1 FY Q2 Q1 FY Q3 Q2 Q1 FY Q3 Q2 FY FY
revenue 61M 60M 241M 58M 58M 216M 53M 53M 51M 219M 54M 59M 184M 134M
costOfRevenue 23M 27M 90M 22M 24M 83M 20M 21M 19M 85M 22M 22M 75M 47M
grossProfit 37M 32M 151M 35M 34M 133M 33M 32M 31M 134M 33M 36M 109M 87M
grossProfitRatio 0.615 0.546 0.613 0.582 0.625 0.604 0.616 0.604 0.619
researchAndDevelopmentExpenses 5M 5M 20M 5M 5M 19M 4M 5M 5M 20M 5M 5M 16M 10M
generalAndAdministrativeExpenses 18M 18M 73M 17M 17M 73M 19M 18M 18M 72M 16M 18M 60M 46M
sellingAndMarketingExpenses 10M 11M 42M 10M 10M 39M 10M 10M 9M 37M 8M 9M 28M 18M
sellingGeneralAndAdministrativeExpenses 28M 29M 115M 27M 24M 111M 29M 27M 27M 110M 25M 27M 89M 64M
otherExpenses 0 -4M 0 0 -2M 275M 4M -360 000 775 000 0 -324 000 0 0 0
operatingExpenses 33M 29M 135M 32M 28M 405M 33M 32M 32M 130M 29M 32M 104M 75M
costAndExpenses 56M 56M 225M 54M 53M 488M 54M 53M 51M 216M 51M 55M 180M 122M
interestIncome 0 0 0 0 0 0 0 905 000 0 0 0 0 0 107 000
interestExpense 3M 2M 12M 3M 3M 6M 2M 905 000 1M 5M 1M 1M 4M 8M
depreciationAndAmortization 6M 6M 25M 6M 5M 32M 9M 8M 8M 33M 8M 9M 25M 18M
ebitda 11M 15M 42M 13M 12M -238M 13M 8M 8M 38M 12M 13M 33M 28M
ebitdaratio 0.176 0.255 0.223 0.19 0.24 0.144 0.163 0.215 0.215
operatingIncome 5M 3M 16M 4M 6M -272M -67 000 -60 000 -664 000 3M 3M 4M 5M 12M
operatingIncomeRatio 0.078 0.051 0.061 0.096 -0.001 -0.001 -0.013 0.063 0.068
totalOtherIncomeExpensesNet -3M 4M -10M 304 000 -2M -4M 4M -360 000 775 000 -4M -1M -611 000 -1M -10M
incomeBeforeTax 2M 7M 6M 4M 4M -276M 2M -1M -937 000 -389 000 2M 3M 4M 2M
incomeBeforeTaxRatio 0.033 0.118 0.066 0.067 0.036 -0.025 -0.019 0.035 0.058
incomeTaxExpense -477 000 2M 8M 384 000 517 000 -21M -170 000 -95 000 -388 000 -1M 1M 2M 2M -971 000
netIncome 2M 5M -2M 3M 3M -254M 2M -1M -549 000 930 000 451 000 1M 2M 3M
netIncomeRatio 0.041 0.08 0.059 0.058 0.04 -0.023 -0.011 0.008 0.022
eps 0.45 0.87 -0.36 0.63 0.63 -47.2 0.39 -0.23 -0.1 0.17 0.08 0.25 0.36 0.66
epsdiluted 0.45 0.85 0.63 0.62 0.39 -0.23 -0.1 0.08 0.24
weightedAverageShsOut 6M 5M 5M 5M 5M 5M 5M 5M 5M 5M 5M 5M 5M 5M
weightedAverageShsOutDil 6M 6M 5M 5M 5M 5M 5M 5M 5M 5M 5M 5M 5M 5M
link Link Link Link Link Link Link Link Link Link
finalLink Link Link Link Link Link Link Link Link Link
filingDate 2025-05-28 2024-06-28 2023-05-30 2022-05-31 2021-06-01
fiscalYear 2025 2024 2023 2022 2021
netInterestIncome -12M -6M -5M -4M -8M
ebit 18M -270M 4M 7M 10M
nonOperatingIncomeExcludingInterest -1M -2M -1M -3M 2M
netIncomeFromContinuingOperations -2M -254M 930 000 2M 3M
netIncomeFromDiscontinuedOperations 0 0 0 0 0
otherAdjustmentsToNetIncome 0 0 0 0 0
netIncomeDeductions 0 0 0 0 0
bottomLineNetIncome -2M -254M 930 000 2M 3M
epsDiluted -0.36 -47.2 0.17 0.35 0.64

Balance Sheet Statement

Property 2025 q3 2025 q2 2025 q1 2024 q3 2024 q2 2024 q1 2023 q4 2023 q3 2023 q2 2023 q1 2022 q4 2022 q3 2022 q1 2021 q1
date 2025-09-30 2025-06-30 2025-03-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-03-31 2021-03-31
symbol MLAB MLAB MLAB MLAB MLAB MLAB MLAB MLAB MLAB MLAB MLAB MLAB MLAB MLAB
reportedCurrency USD USD USD USD USD USD USD USD USD USD USD USD USD USD
cik 724 004 724 004 724 004 724 004 724 004 724 004 724 004 724 004 724 004 724 004 724 004 724 004 724 004 724 004
fillingDate 2025-11-06 2025-08-05 2024-11-07 2024-08-05 2024-02-05 2023-11-06 2023-08-03 2023-02-06 2022-11-03
acceptedDate 2025-11-06 16:51:17 2025-08-05 08:01:12 2025-05-28 08:01:28 2024-11-07 08:05:59 2024-08-05 08:00:59 2024-06-28 17:02:32 2024-02-05 08:01:38 2023-11-06 08:00:52 2023-08-03 08:00:58 2023-05-30 08:01:03 2023-02-06 08:00:41 2022-11-03 08:01:16 2022-05-31 16:09:45 2021-06-01 11:04:21
calendarYear 2026 2026 2025 2025 2024 2024 2024 2023 2023
period Q2 Q1 FY Q2 Q1 FY Q3 Q2 Q1 FY Q3 Q2 FY FY
cashAndCashEquivalents 20M 21M 27M 24M 28M 28M 28M 36M 32M 33M 26M 32M 49M 264M
shortTermInvestments 0 0 0 0 2M 0 2M 2M 0 0 0 0 0 0
cashAndShortTermInvestments 20M 21M 27M 24M 28M 28M 28M 36M 32M 33M 26M 32M 49M 264M
netReceivables 40M 39M 42M 40M 36M 39M 36M 36M 36M 43M 42M 42M 41M 24M
inventory 28M 28M 25M 30M 32M 33M 36M 33M 36M 35M 34M 28M 25M 11M
otherCurrentAssets 9M 10M 3M 14M 11M 3M 5M 4M 4M 4M 3M 4M 0 0
totalCurrentAssets 97M 98M 103M 108M 107M 109M 118M 118M 115M 119M 114M 116M 124M 304M
propertyPlantEquipmentNet 32M 32M 32M 32M 31M 41M 32M 29M 28M 28M 28M 28M 29M 22M
goodwill 188M 188M 182M 184M 180M 180M 346M 283M 284M 286M 286M 278M 291M 161M
intangibleAssets 23M 97M 97M 27M 109M 114M 233M 198M 205M 217M 223M 222M 250M 112M
goodwillAndIntangibleAssets 211M 285M 279M 211M 289M 294M 579M 481M 489M 503M 509M 500M 541M 273M
longTermInvestments 0 0 0 0 82M 0 0 0 0 0 0 0 0 0
taxAssets 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M 708 000 647 000 1M 616 000
otherNonCurrentAssets 88M 19M 18M 102M -70M 867 000 12M 9M 10M 10M 11M 11M 12M 3M
totalNonCurrentAssets 333M 337M 331M 346M 334M 337M 623M 520M 528M 543M 549M 540M 583M 298M
otherAssets 0 0 0 0 0 0 0 0 0 0 0 0 0 0
totalAssets 430M 436M 433M 454M 440M 447M 742M 637M 643M 662M 663M 656M 707M 601M
accountPayables 5M 6M 6M 6M 6M 6M 5M 5M 6M 6M 6M 8M 8M 4M
shortTermDebt 5M 105M 101M 104M 7M 0 3M 3M 3M 0 0 0 0 0
taxPayables 0 12M 11M 9M 2M 2M 11M 8M 8M 9M 2M 1M 8M 8M
deferredRevenue 14M 15M 15M 14M 15M 15M 14M 14M 15M 16M 15M 14M 15M 9M
otherCurrentLiabilities 24M 11M 0 19M 47M 15M 22M 18M 15M 0 21M 20M 0 0
totalCurrentLiabilities 48M 149M 164M 153M 55M 44M 44M 40M 39M 43M 42M 42M 48M 33M
longTermDebt 106M 92M 77M 119M 215M 222M 233M 171M 176M 183M 189M 197M 218M 146M
deferredRevenueNonCurrent 0 0 0 0 0 0 0 0 0 0 0 0 0 0
deferredTaxLiabilitiesNonCurrent 22M 22M 20M 21M 20M 20M 44M 33M 34M 34M 37M 37M 39M 16M
otherNonCurrentLiabilities 76M 0 12M 268 000 282 000 9M 17M 5M 7M 8M 8M 219M 8M 715 000
totalNonCurrentLiabilities 204M 114M 110M 139M 235M 257M 295M 210M 216M 225M 234M 240M 266M 163M
otherLiabilities 0 0 0 0 0 0 0 0 0 0 0 0 0 0
capitalLeaseObligations 0 16M 4M 18M 9M 10M 3M 3M 3M 3M 0 0 3M 1M
totalLiabilities 252M 263M 274M 293M 290M 301M 339M 249M 255M 268M 276M 282M 314M 195M
preferredStock 0 0 0 0 0 0 0 0 0 0 0 0 0 0
commonStock 365M 361M 359M 350M 346M 344M 341M 338M 334M 332M 327M 325M 313M 318M
retainedEarnings -183M -185M -189M -178M -181M -183M 72M 71M 73M 74M 74M 75M 77M 72M
accumulatedOtherComprehensiveIncomeLoss -3M -4M -10M -10M -14M -15M -10M -21M -19M -13M -14M -26M 4M 16M
othertotalStockholdersEquity 0 0 0 0 0 0 0 0 0
totalStockholdersEquity 178M 172M 160M 161M 151M 145M 403M 388M 388M 393M 387M 374M 394M 406M
totalEquity 178M 172M 160M 161M 151M 145M 403M 388M 388M 393M 387M 374M 394M 406M
totalLiabilitiesAndStockholdersEquity 430M 436M 454M 440M 742M 637M 643M 663M 656M
minorityInterest 0 0 0 0 0 0 0 0 0 0 0 0 0 0
totalLiabilitiesAndTotalEquity 430M 436M 433M 454M 440M 447M 742M 637M 643M 662M 663M 656M 707M 601M
totalInvestments 0 0 0 0 2M 0 2M 2M 0 0 0 0 0 0
totalDebt 111M 198M 181M 223M 146M 231M 236M 174M 178M 186M 189M 197M 221M 147M
netDebt 90M 176M 154M 199M 117M 203M 208M 138M 146M 153M 163M 164M 172M -117M
link Link Link Link Link Link Link Link Link Link
finalLink Link Link Link Link Link Link Link Link Link
filingDate 2025-05-28 2024-06-28 2023-05-30 2022-05-31 2021-06-01
fiscalYear 2025 2024 2023 2022 2021
accountsReceivables 42M 39M 43M 41M 24M
otherReceivables 0 0 0 0 0
prepaids 5M 6M 5M 9M 5M
totalPayables 32M 8M 23M 29M 20M
otherPayables 26M 2M 16M 21M 16M
accruedExpenses 13M 3M 2M 2M 2M
capitalLeaseObligationsCurrent 4M 3M 3M 3M 1M
capitalLeaseObligationsNonCurrent 0 7M 0 0 0
treasuryStock 0 0 0 0 0
additionalPaidInCapital 0 0 0 0 0
otherTotalStockholdersEquity 0 0 0 0 0

Cash Flow Statement

Property 2025 q3 2025 q2 2025 q1 2024 q3 2024 q2 2024 q1 2023 q4 2023 q3 2023 q2 2023 q1 2022 q4 2022 q3 2022 q1 2021 q1
date 2025-09-30 2025-06-30 2025-03-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-03-31 2021-03-31
symbol MLAB MLAB MLAB MLAB MLAB MLAB MLAB MLAB MLAB MLAB MLAB MLAB MLAB MLAB
reportedCurrency USD USD USD USD USD USD USD USD USD USD USD USD USD USD
cik 724 004 724 004 724 004 724 004 724 004 724 004 724 004 724 004 724 004 724 004 724 004 724 004 724 004 724 004
fillingDate 2025-11-06 2025-08-05 2024-11-07 2024-08-05 2024-02-05 2023-11-06 2023-08-03 2023-02-06 2022-11-03
acceptedDate 2025-11-06 16:51:17 2025-08-05 08:01:12 2025-05-28 08:01:28 2024-11-07 08:05:59 2024-08-05 08:00:59 2024-06-28 17:02:32 2024-02-05 08:01:38 2023-11-06 08:00:52 2023-08-03 08:00:58 2023-05-30 08:01:03 2023-02-06 08:00:41 2022-11-03 08:01:16 2022-05-31 16:09:45 2021-06-01 11:04:21
calendarYear 2026 2026 2025 2025 2024 2024 2024 2023 2023
period Q2 Q1 FY Q2 Q1 FY Q3 Q2 Q1 FY Q3 Q2 FY FY
netIncome 2M 5M -2M 3M 3M -254M 2M -1M -549 000 930 000 451 000 1M 2M 3M
depreciationAndAmortization 6M 6M 25M 6M 5M 32M 9M 8M 8M 33M 9M 8M 25M 18M
deferredIncomeTax 0 0 -72 000 0 0 -28M 0 0 -5M -3M 0 0 128 000 -4M
stockBasedCompensation 4M 4M 13M 4M 3M 12M 3M 3M 3M 13M 2M 4M 11M 9M
changeInWorkingCapital -5M -8M 7M 338 000 -338 000 6M -103 000 -1M -1M -17M -4M -5M -7M 5M
accountsReceivables -2M 3M -3M -4M 3M 5M 3M -1M 6M -2M 678 000 -1M -7M -647 000
inventory -766 000 -3M 1M 627 000 -671 000 3M 401 000 1M -1M -10M -5M -1M -1M 929 000
accountsPayables -1M 212 000 -388 000 199 000 -388 000 -97 000 -349 000 -768 000 -539 000 -2M -2M 448 000 1M 967 000
otherWorkingCapital -2M -8M 9M 4M -3M -1M -3M -642 000 -6M -3M 2M -2M -765 000 4M
otherNonCashItems 2M -5M 4M -8M 10M 277M -3M 1M 5M 2M 733 000 1M 8M 5M
netCashProvidedByOperatingActivities 8M 2M 47M 5M 10M 44M 12M 10M 10M 28M 8M 11M 39M 37M
investmentsInPropertyPlantAndEquipment -1M -1M -4M -2M -891 000 -3M -1M -634 000 -270 000 -5M -2M -2M -4M -2M
acquisitionsNet 0 0 0 0 0 -79M -80M 0 0 -5M 0 0 -301M 0
purchasesOfInvestments 0 0 0 0 0 0 0 0 0 0 0 0 0 0
salesMaturitiesOfInvestments 0 0 0 0 0 0 0 0 0 0 0 0 0 0
otherInvestingActivites 0 0 0 0 0 0 0 -5M 0
netCashUsedForInvestingActivites -1M -1M -2M -891 000 -81M -634 000 -270 000 -7M -2M
debtRepayment -6M 3M -7M -7M -9M -5M -8M -8M -20M
commonStockIssued 0 0 0 0 2000 304 000 0 0 0
commonStockRepurchased 0 0 0 0 0 0 -2000 -2000 0 0 0 0 0 0
dividendsPaid -882 000 -873 000 -866 000 -863 000 -862 000 -862 000 -859 000 -855 000 -852 000
otherFinancingActivites -564 000 -11M -307 000 -1M 71M -2000 -660 000 -28 000 2M
netCashUsedProvidedByFinancingActivities -8M -8M -9M -9M 61M -6M -10M -9M -19M
effectOfForexChangesOnCash -104 000 2M 1M 992 000 -175 000 -359 000 1M -341 000 -684 000 -2M 1M -2M -1M 1M
netChangeInCash -857 000 -6M -893 000 -4M 258 000 -5M -7M 3M -534 000 -16M -6M -11M -215M 182M
cashAtEndOfPeriod 20M 21M 27M 24M 28M 28M 28M 36M 32M 33M 26M 32M 49M 264M
cashAtBeginningOfPeriod 21M 27M 28M 28M 28M 33M 36M 32M 33M 49M 32M 44M 264M 81M
operatingCashFlow 8M 2M 47M 5M 10M 44M 12M 10M 10M 28M 8M 11M 39M 37M
capitalExpenditure -1M -1M -4M -2M -891 000 -3M -1M -634 000 -270 000 -5M -2M -2M -4M -2M
freeCashFlow 7M 884 000 42M 3M 10M 42M 10M 9M 10M 23M 6M 9M 35M 35M
link Link Link Link Link Link Link Link Link Link
finalLink Link Link Link Link Link Link Link Link Link
filingDate 2025-05-28 2024-06-28 2023-05-30 2022-05-31 2021-06-01
fiscalYear 2025 2024 2023 2022 2021
otherInvestingActivities -250 000 0 0 0 0
netCashProvidedByInvestingActivities -4M -81M -9M -305M -2M
netDebtIssuance -42M 38M -36M 49M 0
longTermNetDebtIssuance -42M 38M -36M 49M 0
shortTermNetDebtIssuance 0 0 0 0 0
netStockIssuance 0 0 0 0 146M
netCommonStockIssuance 0 0 0 0 146M
commonStockIssuance 0 0 0 0 146M
netPreferredStockIssuance 0 0 0 0 0
netDividendsPaid -3M -3M -3M -3M -3M
commonDividendsPaid -3M -3M -3M -3M -3M
preferredDividendsPaid 0 0 0 0 0
otherFinancingActivities 1M -1M 6M 7M 3M
netCashProvidedByFinancingActivities -45M 33M -33M 53M 146M
incomeTaxesPaid 6M 5M 1M 3M 1M
interestPaid 11M 5M 3M 3M 2M

Earning call transcript

Press-releases

Show financial reports only

2026-08-10 ET
Mesa Labs Announces First Quarter Results
2026-08-03 ET
Mesa Labs Announces First Quarter Financial Results Release Date and Inaugural Earnings Conference Call
2026-07-06 ET
MESA LABS DECLARES QUARTERLY DIVIDEND
2026-05-27 12:00 ET
Mesa Labs Announces Fourth Quarter and Fiscal Year 2026 Results
2026-05-05 ET
Mesa Laboratories, Inc. to Announce Fourth Quarter and Full Fiscal Year Results on May 27, 2026
2026-04-02 ET
MESA LABS DECLARES QUARTERLY DIVIDEND
2026-03-09 ET
Mesa Laboratories Announces CEO Transition and Appointment of Siddhartha Kadia as President and CEO
2026-02-03 ET
Mesa Labs Announces Third Quarter Results
2026-01-07 ET
MESA LABS DECLARES QUARTERLY DIVIDEND
2025-12-18 ET
Mesa Labs to Present at the 44th Annual J.P. Morgan Healthcare Conference on January 14, 2026
2025-12-03 ET
Mesa Laboratories, Inc. to Announce Third Quarter Results on February 3, 2026
2025-11-12 ET
Mesa Laboratories, Inc. to Participate in Upcoming Investor Conferences
2025-11-06 21:15 ET
Mesa Labs Announces Second Quarter Results
2025-10-03 ET
Mesa Laboratories, Inc. to Announce Second Quarter Results on November 6, 2025
2025-10-03 ET
MESA LABS DECLARES QUARTERLY DIVIDEND
2025-08-18 ET
Mesa Laboratories Executes Previously-Announced Strategic Financing Plan
2025-08-05 ET
Mesa Labs Announces First Quarter Results
2025-07-03 ET
MESA LABS DECLARES QUARTERLY DIVIDEND
2025-07-02 ET
Mesa Laboratories, Inc. to Announce First Quarter Results on August 5, 2025
2025-05-28 ET
Mesa Labs Announces Fourth Quarter and Full Fiscal Year 2025 Results
2025-04-07 ET
MESA LABS DECLARES QUARTERLY DIVIDEND
2025-02-04 ET
Mesa Labs Announces Third Quarter Results
2025-01-17 ET
Mesa Laboratories, Inc. to Announce Third Quarter Results on February 4, 2025
2025-01-06 ET
MESA LABS DECLARES QUARTERLY DIVIDEND
2024-11-07 13:00 ET
Mesa Labs Announces Second Quarter Results
2024-10-02 18:00 ET
MESA LABS DECLARES QUARTERLY DIVIDEND
2024-08-05 12:00 ET
Mesa Labs Announces First Quarter Results
2024-07-08 18:00 ET
MESA LABS DECLARES QUARTERLY DIVIDEND
2024-06-05 10:00 ET
Mesa Labs Announces Fourth Quarter and Full Fiscal Year 2024 Results
2024-05-31 10:00 ET
Mesa Laboratories, Inc. Revises Earnings Announcement date for Unaudited Fourth Quarter and Full Fiscal Year 2024 Results
2024-05-22 10:00 ET
Mesa Laboratories, Inc. Revises Earnings Announcement date for Unaudited Fourth Quarter and Full Fiscal Year 2024 Results to May 31, 2024
2024-04-08 12:00 ET
MESA LABS ANNOUNCES AMENDMENT TO CREDIT FACILITY AND REPURCHASE OF SENIOR CONVERTIBLE NOTES
2024-04-04 22:24 ET
MESA LABS DECLARES QUARTERLY DIVIDEND
2024-04-01 14:27 ET
Mesa Laboratories, Inc. to Announce Unaudited Fourth Quarter and Full Fiscal Year 2024 Results on May 24, 2024
2024-03-15 11:00 ET
Mesa Labs Releases Second Annual Responsible Business Program Brochure
2024-02-05 13:00 ET
Mesa Labs Announces Third Quarter Results
2024-01-08 13:00 ET
Mesa Laboratories Appoints Mark Capone to its Board of Directors
2024-01-04 20:00 ET
MESA LABS DECLARES QUARTERLY DIVIDEND
2024-01-03 13:00 ET
Mesa Labs Completes the Acquisition of GKE Science & Technology Co.
2023-12-14 15:47 ET
Mesa Laboratories, Inc. to Announce Second Quarter Results on February 5, 2024
2023-11-06 13:00 ET
Mesa Labs Announces Second Quarter Results
2023-10-16 07:00 ET
Mesa Labs Acquires GKE-GmbH Complementary Sterilization Indicators and Healthcare Channels to Mesa’s SDC Platform
2023-10-03 12:00 ET
MESA LABS DECLARES QUARTERLY DIVIDEND
2023-09-13 17:37 ET
Mesa Laboratories, Inc. to Announce Second Quarter Results on November 6, 2023
2023-08-24 20:02 ET
Mesa Laboratories, Inc. Announces Commitment to Disclose Scope 1 and 2 Greenhouse Gas Emissions
2023-08-03 12:00 ET
Mesa Labs Announces First Quarter Results
2023-07-05 19:00 ET
MESA LABS DECLARES QUARTERLY DIVIDEND
2023-06-21 15:50 ET
Mesa Laboratories, Inc. to Announce First Quarter Results on August 3, 2023
2023-05-25 12:00 ET
Mesa Labs Announces Unaudited Fourth Quarter and Full Fiscal Year 2023 Results
2023-04-03 22:00 ET
MESA LABS DECLARES QUARTERLY DIVIDEND
2023-03-13 12:00 ET
Mesa Laboratories, Inc. Reports Immaterial Financial Exposure to Silicon Valley Bank Closure
2023-03-09 13:00 ET
Mesa Laboratories, Inc. to Announce Fourth Quarter and Full Fiscal Year 2023 Results on May 25, 2023
2023-02-13 13:00 ET
Mesa Labs Releases Environmental, Social, and Governance Program Brochure
2023-02-06 13:36 ET
Mesa Labs Announces Third Quarter Results
2023-01-03 22:00 ET
Mesa Labs Declares Quarterly Dividend
2022-12-16 16:59 ET
Mesa Laboratories, Inc. to Announce Third Quarter Results on February 6, 2023
2022-11-17 13:04 ET
Mesa Labs Acquires Belyntic’s Peptide Purification Business
2022-11-04 19:49 ET
Mesa Laboratories, Inc. Appoints Shiraz Ladiwala as Lead Independent Director
2022-11-03 12:00 ET
Mesa Labs Announces Second Quarter Results
2022-10-03 18:00 ET
MESA LABS DECLARES QUARTERLY DIVIDEND
2022-08-04 12:00 ET
Mesa Labs Announces First Quarter Results
2022-07-06 23:00 ET
MESA LABS DECLARES QUARTERLY DIVIDEND
2022-06-27 12:01 ET
Mesa Laboratories Appoints Tony Tripeny to its Board of Directors
2022-05-31 12:00 ET
Mesa Labs Reports Fourth Quarter and Full Fiscal Year Results
2022-04-06 17:10 ET
Mesa Labs Declares Quarterly Dividend
2022-02-03 13:00 ET
Mesa Labs Announces Third Quarter Results
2022-01-06 20:00 ET
MESA LABS DECLARES QUARTERLY DIVIDEND
2021-11-04 12:00 ET
Mesa Labs Announces Second Quarter Results
2021-10-29 12:00 ET
Leader in Corporate Development and Strategy Joins Mesa Labs Board of Directors
2021-10-20 16:05 ET
Mesa Labs Closes Acquisition of Agena Bioscience
2021-10-01 19:00 ET
Mesa Labs Declares Quarterly Dividend
2021-09-14 11:00 ET
Mesa Labs Announces Agreement to Acquire Agena Bioscience, Inc.
2021-08-05 12:00 ET
Mesa Labs Announces First Quarter Results
2021-07-06 23:19 ET
MESA LABS DECLARES QUARTERLY DIVIDEND
2021-06-01 12:00 ET
Mesa Labs Reports Fourth Quarter and Full Fiscal Year Results
2021-04-05 21:00 ET
MESA LABS DECLARES QUARTERLY DIVIDEND
2021-02-03 13:00 ET
Mesa Labs Reports Third Quarter Results for FY21
2021-01-05 22:00 ET
Mesa Labs Declares Quarterly Dividend
2020-11-05 13:00 ET
Mesa Labs Reports Second Quarter Results for FY21
2020-10-01 20:00 ET
MESA LABS DECLARES QUARTERLY DIVIDEND
2020-08-06 12:00 ET
Mesa Labs Reports First Quarter Results
2020-07-06 16:00 ET
MESA LABS DECLARES QUARTERLY DIVIDEND
2020-06-16 15:52 ET
Mesa Laboratories, Inc. Announces Full Exercise of Underwriters’ Option to Purchase Additional Shares of Common Stock in Public Offering
2020-06-10 00:15 ET
Mesa Laboratories, Inc. Announces Upsizing and Pricing of Public Offering of Common Stock
2020-06-08 20:01 ET
Mesa Laboratories, Inc. Announces Proposed Public Offering of Common Stock
2020-06-01 12:00 ET
Mesa Labs Reports Fourth Quarter and Full Fiscal Year Results
2020-05-15 12:00 ET
Life Sciences Executive Shannon Hall Joins Mesa Labs Board of Directors
2020-04-01 22:00 ET
MESA LABS DECLARES QUARTERLY DIVIDEND
2020-02-10 13:00 ET
Mesa Labs Reports Third Quarter Results
2020-01-10 00:00 ET
MESA LABS DECLARES QUARTERLY DIVIDEND
2019-11-06 13:00 ET
Mesa Labs Reports Record Second Quarter Revenues and Adjusted Operating Income
2019-11-01 00:55 ET
Mesa Labs Acquires Gyros Protein Technologies
2019-10-01 21:00 ET
MESA LABS DECLARES QUARTERLY DIVIDEND

SEC forms

Show financial reports only

SEC form 10
2026-08-10 21:17 ET
Mesa Laboratories published news for 2026 q2
SEC form 8
2026-08-10 20:03 ET
Mesa Laboratories published news for 2026 q2
SEC form 8
2026-08-10 20:03 ET
Mesa Laboratories published news for 2026 q2
SEC form 8
2026-07-30 21:18 ET
Mesa Laboratories published news for 2026 q2
SEC form 8
2026-07-30 21:18 ET
Mesa Laboratories published news for 2026 q2
SEC form 10
2026-06-02 22:19 ET
Mesa Laboratories published news for 2026 q1
SEC form 8
2026-05-27 12:00 ET
Mesa Laboratories published news for 2026 q1
SEC form 8
2026-05-27 12:00 ET
Mesa Laboratories published news for 2026 q1
SEC form 10
2026-02-03 08:01 ET
Mesa Laboratories reported for 2025 q4
SEC form 8
2026-02-03 08:00 ET
Mesa Laboratories published news for 2025 q4
SEC form 8
2026-02-03 08:00 ET
Mesa Laboratories published news for 2025 q4
SEC form 10
2025-11-06 16:51 ET
Mesa Laboratories reported for 2025 q3
SEC form 8
2025-11-06 16:22 ET
Mesa Laboratories published news for 2025 q3
SEC form 8
2025-11-06 16:22 ET
Mesa Laboratories published news for 2025 q3
SEC form 10
2025-08-05 12:01 ET
Mesa Laboratories reported for 2025 q2
SEC form 8
2025-08-05 12:00 ET
Mesa Laboratories published news for 2025 q2
SEC form 8
2025-08-05 12:00 ET
Mesa Laboratories reported for 2025 q2
SEC form 8
2025-06-06 19:00 ET
Mesa Laboratories published news for 2025 q1
SEC form 8
2025-06-06 19:00 ET
Mesa Laboratories published news for 2025 q1
SEC form 10
2025-05-28 12:01 ET
Mesa Laboratories reported for 2025 q1
SEC form 8
2025-05-28 12:00 ET
Mesa Laboratories published news for 2025 q1
SEC form 8
2025-05-28 12:00 ET
Mesa Laboratories published news for 2025 q1
SEC form 10
2025-02-04 08:00 ET
Mesa Laboratories reported for 2024 q4
SEC form 8
2025-02-04 08:00 ET
Mesa Laboratories published news for 2024 q4
SEC form 8
2025-02-04 08:00 ET
Mesa Laboratories published news for 2024 q4
SEC form 10
2025-02-04 00:00 ET
Mesa Laboratories published news for 2024 q4
SEC form 10
2024-11-07 08:05 ET
Mesa Laboratories published news for 2024 q3
SEC form 8
2024-11-07 08:03 ET
Mesa Laboratories published news for 2024 q3
SEC form 8
2024-11-07 08:03 ET
Mesa Laboratories published news for 2024 q3
SEC form 10
2024-08-05 08:00 ET
Mesa Laboratories reported for 2024 q2
SEC form 8
2024-08-05 08:00 ET
Mesa Laboratories published news for 2024 q2
SEC form 8
2024-08-05 08:00 ET
Mesa Laboratories published news for 2024 q2
SEC form 10
2024-08-05 00:00 ET
Mesa Laboratories published news for 2024 q2
SEC form 10
2024-06-28 17:02 ET
Mesa Laboratories reported for 2024 q1
SEC form 10
2024-06-28 00:00 ET
Mesa Laboratories reported for 2024 q1
SEC form 8
2024-06-05 00:00 ET
Mesa Laboratories published news for 2024 q1
SEC form 8
2024-06-05 00:00 ET
Mesa Laboratories reported for 2024 q1
SEC form 10
2024-02-05 00:00 ET
Mesa Laboratories reported for 2023 q4
SEC form 8
2024-02-05 00:00 ET
Mesa Laboratories published news for 2023 q4
SEC form 8
2024-02-05 00:00 ET
Mesa Laboratories reported for 2023 q4
SEC form 10
2023-11-06 08:00 ET
Mesa Laboratories reported for 2023 q3
SEC form 8
2023-11-06 08:00 ET
Mesa Laboratories published news for 2023 q3
SEC form 10
2023-11-06 00:00 ET
Mesa Laboratories published news for 2023 q3
SEC form 10
2023-08-03 08:00 ET
Mesa Laboratories reported for 2023 q2
SEC form 6
2023-08-03 08:00 ET
Mesa Laboratories published news for 2023 q2
SEC form 10
2023-08-03 00:00 ET
Mesa Laboratories published news for 2023 q2
SEC form 8
2023-08-03 00:00 ET
Mesa Laboratories published news for 2023 q2
SEC form 6
2023-07-14 08:00 ET
Mesa Laboratories published news for 2023 q2
SEC form 6
2023-07-03 10:27 ET
Mesa Laboratories published news for 2023 q2
SEC form 10
2023-05-30 00:00 ET
Mesa Laboratories published news for 2023 q1
SEC form 6
2023-05-25 08:00 ET
Mesa Laboratories reported for 2023 q1
SEC form 8
2023-05-25 00:00 ET
Mesa Laboratories published news for 2023 q1
SEC form 6
2023-05-08 08:00 ET
Mesa Laboratories published news for 2023 q1
SEC form 6
2023-03-13 08:00 ET
Mesa Laboratories published news for 2022 q4
SEC form 6
2023-02-06 08:37 ET
Mesa Laboratories published news for 2022 q4
SEC form 10
2023-02-06 08:00 ET
Mesa Laboratories reported for 2022 q4
SEC form 10
2023-02-06 00:00 ET
Mesa Laboratories reported for 2022 q4
SEC form 8
2023-02-06 00:00 ET
Mesa Laboratories reported for 2022 q4
SEC form 6
2023-01-04 14:13 ET
Mesa Laboratories published news for 2022 q4
SEC form 6
2022-11-21 16:44 ET
Mesa Laboratories published news for 2022 q3
SEC form 6
2022-11-04 15:50 ET
Mesa Laboratories published news for 2022 q3
SEC form 6
2022-11-04 14:11 ET
Mesa Laboratories published news for 2022 q3
SEC form 6
2022-11-03 08:01 ET
Mesa Laboratories published news for 2022 q3
SEC form 10
2022-11-03 08:01 ET
Mesa Laboratories reported for 2022 q3
SEC form 10
2022-11-03 00:00 ET
Mesa Laboratories reported for 2022 q3
SEC form 8
2022-11-03 00:00 ET
Mesa Laboratories reported for 2022 q3
SEC form 6
2022-08-26 16:30 ET
Mesa Laboratories published news for 2022 q2
SEC form 6
2022-08-09 17:28 ET
Mesa Laboratories published news for 2022 q2
SEC form 10
2022-08-04 08:01 ET
Mesa Laboratories reported for 2022 q2
SEC form 6
2022-08-04 08:00 ET
Mesa Laboratories published news for 2022 q2
SEC form 10
2022-08-04 00:00 ET
Mesa Laboratories reported for 2022 q2
SEC form 8
2022-08-04 00:00 ET
Mesa Laboratories reported for 2022 q2
SEC form 6
2022-07-14 08:00 ET
Mesa Laboratories published news for 2022 q2
SEC form 6
2022-06-27 08:00 ET
Mesa Laboratories published news for 2022 q1
SEC form 10
2022-05-31 16:09 ET
Mesa Laboratories reported for 2022 q1
SEC form 6
2022-05-31 08:00 ET
Mesa Laboratories published news for 2022 q1
SEC form 10
2022-05-31 00:00 ET
Mesa Laboratories reported for 2022 q1
SEC form 8
2022-05-31 00:00 ET
Mesa Laboratories reported for 2022 q1
SEC form 6
2022-04-08 19:06 ET
Mesa Laboratories published news for 2022 q1
SEC form 6
2022-04-05 17:01 ET
Mesa Laboratories published news for 2022 q1
SEC form 6
2022-03-30 17:22 ET
Mesa Laboratories published news for 2021 q4
SEC form 10
2022-02-03 08:01 ET
Mesa Laboratories published news for 2021 q4
SEC form 6
2022-02-03 08:00 ET
Mesa Laboratories published news for 2021 q4
SEC form 10
2022-02-03 00:00 ET
Mesa Laboratories published news for 2021 q4
SEC form 8
2022-02-03 00:00 ET
Mesa Laboratories published news for 2021 q4
SEC form 6
2021-12-23 14:38 ET
Mesa Laboratories published news for 2021 q3
SEC form 6
2021-12-22 11:57 ET
Mesa Laboratories published news for 2021 q3
SEC form 6
2021-11-19 12:48 ET
Mesa Laboratories published news for 2021 q3
SEC form 10
2021-11-04 08:02 ET
Mesa Laboratories published news for 2021 q3
SEC form 6
2021-11-04 08:00 ET
Mesa Laboratories published news for 2021 q3
SEC form 10
2021-11-04 00:00 ET
Mesa Laboratories published news for 2021 q3
SEC form 8
2021-11-04 00:00 ET
Mesa Laboratories published news for 2021 q3
SEC form 6
2021-10-29 08:00 ET
Mesa Laboratories published news for 2021 q3
SEC form 6
2021-10-21 08:00 ET
Mesa Laboratories published news for 2021 q3
SEC form 6
2021-09-29 17:05 ET
Mesa Laboratories published news for 2021 q2
SEC form 6
2021-09-14 08:00 ET
Mesa Laboratories published news for 2021 q2
SEC form 6
2021-09-03 17:00 ET
Mesa Laboratories published news for 2021 q2
SEC form 6
2021-08-27 13:22 ET
Mesa Laboratories published news for 2021 q2
SEC form 10
2021-08-05 08:01 ET
Mesa Laboratories published news for 2021 q2
SEC form 6
2021-08-05 08:00 ET
Mesa Laboratories published news for 2021 q2
SEC form 10
2021-08-05 00:00 ET
Mesa Laboratories published news for 2021 q2
SEC form 8
2021-08-05 00:00 ET
Mesa Laboratories published news for 2021 q2
SEC form 6
2021-07-16 06:02 ET
Mesa Laboratories published news for 2021 q2
SEC form 10
2021-06-01 11:04 ET
Mesa Laboratories published news for 2021 q1
SEC form 6
2021-06-01 08:00 ET
Mesa Laboratories published news for 2021 q1
SEC form 10
2021-06-01 00:00 ET
Mesa Laboratories published news for 2021 q1
SEC form 8
2021-06-01 00:00 ET
Mesa Laboratories published news for 2021 q1
SEC form 6
2021-03-08 15:55 ET
Mesa Laboratories published news for 2020 q4
SEC form 10
2021-02-03 08:01 ET
Mesa Laboratories published news for 2020 q4
SEC form 6
2021-02-03 08:00 ET
Mesa Laboratories published news for 2020 q4
SEC form 6
2020-11-13 17:21 ET
Mesa Laboratories published news for 2020 q3
SEC form 6
2020-11-12 12:24 ET
Mesa Laboratories published news for 2020 q3
SEC form 10
2020-11-05 08:01 ET
Mesa Laboratories published news for 2020 q3
SEC form 6
2020-11-05 08:00 ET
Mesa Laboratories published news for 2020 q3
SEC form 6
2020-10-05 20:01 ET
Mesa Laboratories published news for 2020 q3
SEC form 6
2020-10-01 11:28 ET
Mesa Laboratories published news for 2020 q3